Search

H Grant Skaggs Jr

Examiner (ID: 16447)

Most Active Art Unit
3101
Art Unit(s)
3651, 1301, 3615, 3653, 2899, 3101
Total Applications
2062
Issued Applications
1836
Pending Applications
39
Abandoned Applications
187

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6292214 [patent_doc_number] => 20100159440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'METHODS FOR IDENTIFYING AGENTS THAT MODULATE p44' [patent_app_type] => utility [patent_app_number] => 12/331285 [patent_app_country] => US [patent_app_date] => 2008-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 36553 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20100159440.pdf [firstpage_image] =>[orig_patent_app_number] => 12331285 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/331285
METHODS FOR IDENTIFYING AGENTS THAT MODULATE p44 Dec 8, 2008 Abandoned
Array ( [id] => 5574949 [patent_doc_number] => 20090142310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'METHOD OF TREATING INFLAMMATORY ARTHROPATHIES WITH SUPPRESSORS OF CPG OLIGONUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 12/325106 [patent_app_country] => US [patent_app_date] => 2008-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 17130 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142310.pdf [firstpage_image] =>[orig_patent_app_number] => 12325106 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/325106
Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides Nov 27, 2008 Issued
Array ( [id] => 6538425 [patent_doc_number] => 20100221745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'ABNORMAL PRION PROTEIN BINDER, AND METHOD FOR DETECTION OF ABNORMAL PRION PROTEIN' [patent_app_type] => utility [patent_app_number] => 12/742169 [patent_app_country] => US [patent_app_date] => 2008-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7993 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221745.pdf [firstpage_image] =>[orig_patent_app_number] => 12742169 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/742169
Abnormal prion protein binder, and method for detection of abnormal prion protein Nov 19, 2008 Issued
Array ( [id] => 5452603 [patent_doc_number] => 20090068640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'METHODS FOR DETECTING AND INACTIVATING A PRION' [patent_app_type] => utility [patent_app_number] => 12/269479 [patent_app_country] => US [patent_app_date] => 2008-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7594 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068640.pdf [firstpage_image] =>[orig_patent_app_number] => 12269479 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/269479
METHODS FOR DETECTING AND INACTIVATING A PRION Nov 11, 2008 Abandoned
Array ( [id] => 5514868 [patent_doc_number] => 20090215175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'MODULATION OF THE POLIOVIRUS RECEPTOR FUNCTION' [patent_app_type] => utility [patent_app_number] => 12/269137 [patent_app_country] => US [patent_app_date] => 2008-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 22253 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215175.pdf [firstpage_image] =>[orig_patent_app_number] => 12269137 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/269137
MODULATION OF THE POLIOVIRUS RECEPTOR FUNCTION Nov 11, 2008 Abandoned
Array ( [id] => 9238678 [patent_doc_number] => 08603468 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Neutralization of HCV' [patent_app_type] => utility [patent_app_number] => 12/741612 [patent_app_country] => US [patent_app_date] => 2008-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 24 [patent_no_of_words] => 27901 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12741612 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/741612
Neutralization of HCV Nov 3, 2008 Issued
Array ( [id] => 9704109 [patent_doc_number] => 08829174 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-09 [patent_title] => 'HCV vaccines and methods for using the same' [patent_app_type] => utility [patent_app_number] => 13/127008 [patent_app_country] => US [patent_app_date] => 2008-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11608 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13127008 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/127008
HCV vaccines and methods for using the same Oct 28, 2008 Issued
Array ( [id] => 6054614 [patent_doc_number] => 20110110974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'METHODS AND KITS FOR INDUCING A CTL RESPONSE USING A PRIME BOOST REGIMEN' [patent_app_type] => utility [patent_app_number] => 12/734397 [patent_app_country] => US [patent_app_date] => 2008-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 16855 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110974.pdf [firstpage_image] =>[orig_patent_app_number] => 12734397 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/734397
METHODS AND KITS FOR INDUCING A CTL RESPONSE USING A PRIME BOOST REGIMEN Oct 27, 2008 Abandoned
Array ( [id] => 5473005 [patent_doc_number] => 20090246171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'AUTOMATIC SYSTEM FOR DOSE CONTROL IN TREATING HEPATITIS C USING INFUSION PUMPS' [patent_app_type] => utility [patent_app_number] => 12/257307 [patent_app_country] => US [patent_app_date] => 2008-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8995 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246171.pdf [firstpage_image] =>[orig_patent_app_number] => 12257307 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/257307
AUTOMATIC SYSTEM FOR DOSE CONTROL IN TREATING HEPATITIS C USING INFUSION PUMPS Oct 22, 2008 Abandoned
Array ( [id] => 8807990 [patent_doc_number] => 08445642 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-05-21 [patent_title] => 'Methods to differentiate protein conformers' [patent_app_type] => utility [patent_app_number] => 12/251456 [patent_app_country] => US [patent_app_date] => 2008-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21812 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 233 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12251456 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/251456
Methods to differentiate protein conformers Oct 13, 2008 Issued
Array ( [id] => 9977332 [patent_doc_number] => 09023643 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-05 [patent_title] => 'Medicaments and methods for treating mesothelioma' [patent_app_type] => utility [patent_app_number] => 12/682457 [patent_app_country] => US [patent_app_date] => 2008-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 5203 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12682457 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/682457
Medicaments and methods for treating mesothelioma Oct 9, 2008 Issued
Array ( [id] => 5545417 [patent_doc_number] => 20090155294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'HCV VACCINES' [patent_app_type] => utility [patent_app_number] => 12/248587 [patent_app_country] => US [patent_app_date] => 2008-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14499 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155294.pdf [firstpage_image] =>[orig_patent_app_number] => 12248587 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/248587
HCV VACCINES Oct 8, 2008 Abandoned
Array ( [id] => 5278003 [patent_doc_number] => 20090130135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'HCV VACCINES' [patent_app_type] => utility [patent_app_number] => 12/248744 [patent_app_country] => US [patent_app_date] => 2008-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14566 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130135.pdf [firstpage_image] =>[orig_patent_app_number] => 12248744 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/248744
HCV VACCINES Oct 8, 2008 Abandoned
Array ( [id] => 5585015 [patent_doc_number] => 20090104217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Pharmaceutical Composition Comprising An Antigen' [patent_app_type] => utility [patent_app_number] => 12/248397 [patent_app_country] => US [patent_app_date] => 2008-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4278 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20090104217.pdf [firstpage_image] =>[orig_patent_app_number] => 12248397 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/248397
Pharmaceutical Composition Comprising An Antigen Oct 8, 2008 Abandoned
Array ( [id] => 5574937 [patent_doc_number] => 20090142298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Apolactoferrin Compositions and Methods for Their Use in the Treatment of Viral Hepatitis C' [patent_app_type] => utility [patent_app_number] => 12/203813 [patent_app_country] => US [patent_app_date] => 2008-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6104 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142298.pdf [firstpage_image] =>[orig_patent_app_number] => 12203813 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/203813
Apolactoferrin Compositions and Methods for Their Use in the Treatment of Viral Hepatitis C Sep 2, 2008 Abandoned
Array ( [id] => 10574172 [patent_doc_number] => 09296799 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-29 [patent_title] => 'Process for isolation and purification of a target protein free of prion protein (PrPSC)' [patent_app_type] => utility [patent_app_number] => 12/733306 [patent_app_country] => US [patent_app_date] => 2008-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7076 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 181 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12733306 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/733306
Process for isolation and purification of a target protein free of prion protein (PrPSC) Aug 24, 2008 Issued
Array ( [id] => 5271029 [patent_doc_number] => 20090074805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Yeast-based Therapeutic for Chronic Hepatitis C Infection' [patent_app_type] => utility [patent_app_number] => 12/196439 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 31934 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074805.pdf [firstpage_image] =>[orig_patent_app_number] => 12196439 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/196439
Yeast-based therapeutic for chronic hepatitis C infection Aug 21, 2008 Issued
Array ( [id] => 6070125 [patent_doc_number] => 20110044975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'TREATMENT OF PRION PROTEIN RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 12/672737 [patent_app_country] => US [patent_app_date] => 2008-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17132 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20110044975.pdf [firstpage_image] =>[orig_patent_app_number] => 12672737 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/672737
TREATMENT OF PRION PROTEIN RELATED DISEASES Aug 7, 2008 Abandoned
Array ( [id] => 5984591 [patent_doc_number] => 20110097332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'Composition and Method of Use for HCV Immunization' [patent_app_type] => utility [patent_app_number] => 12/672656 [patent_app_country] => US [patent_app_date] => 2008-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 21489 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20110097332.pdf [firstpage_image] =>[orig_patent_app_number] => 12672656 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/672656
Composition and Method of Use for HCV Immunization Aug 5, 2008 Abandoned
Array ( [id] => 7488756 [patent_doc_number] => 08029785 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-04 [patent_title] => 'Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases' [patent_app_type] => utility [patent_app_number] => 12/176793 [patent_app_country] => US [patent_app_date] => 2008-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9586 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/029/08029785.pdf [firstpage_image] =>[orig_patent_app_number] => 12176793 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/176793
Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases Jul 20, 2008 Issued
Menu